Search research articles
Contact Us
Filters
Showing results (141-150 of 153) with videos related to
Page
of 16
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 4, 2023
Structural and functional characterization of capsid binding by anti-AAV9 monoclonal antibodies from infants after SMA gene therapy
Grant J Logan, Mario Mietzsch, Neeta Khandekar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2014
DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival
Liam Cornell, Joanne M Munck, Clara Alsinet, et al.
Mabs
|
May 24, 2021
Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
Romain Rouet, Ohan Mazigi, Gregory J Walker, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 28, 2022
Corrigendum to "Discovery of 4-aminopyrimidine analogs as highly potent dual P70S6K/Akt inhibitors" [Bioorgan. Med. Chem. Lett. 50 (2021) 128352]
Yufang Xiao, Bayard R Huck, Ruoxi Lan, et al.
Journal of Medicinal Chemistry
|
October 1, 2021
Identification of Clinical Candidate M2698, a Dual p70S6K and Akt Inhibitor, for Treatment of PAM Pathway-Altered Cancers
Lizbeth DeSelm, Bayard Huck, Ruoxi Lan, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 5, 2021
Discovery of 4-aminopyrimidine analogs as highly potent dual P70S6K/Akt inhibitors
Yufang Xiao, Bayard R Huck, Ruoxi Lan, et al.
Micropublication Biology
|
June 12, 2025
Olfactory cues elicit species-specific locomotive responses in poison frog tadpoles
Mina E Phipps, Penelope R Baker, Luise Bachmann, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 2, 2025
Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodies
Ohan Mazigi, David B Langley, Jake Y Henry, et al.
Nature Communications
|
February 8, 2023
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
Romain Rouet, Jake Y Henry, Matt D Johansen, et al.
Micropublication Biology
|
June 19, 2025
Velvety tree ant extract is a chemotaxis repellent for <i>C. elegans</i>
Malaya Gaerlan, Marco Carrillo, Sofia Ceva, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 153) with videos related to
Sort By:
Page
of 16
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 4, 2023
Structural and functional characterization of capsid binding by anti-AAV9 monoclonal antibodies from infants after SMA gene therapy
Grant J Logan, Mario Mietzsch, Neeta Khandekar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2014
DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival
Liam Cornell, Joanne M Munck, Clara Alsinet, et al.
Mabs
|
May 24, 2021
Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
Romain Rouet, Ohan Mazigi, Gregory J Walker, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 28, 2022
Corrigendum to "Discovery of 4-aminopyrimidine analogs as highly potent dual P70S6K/Akt inhibitors" [Bioorgan. Med. Chem. Lett. 50 (2021) 128352]
Yufang Xiao, Bayard R Huck, Ruoxi Lan, et al.
Journal of Medicinal Chemistry
|
October 1, 2021
Identification of Clinical Candidate M2698, a Dual p70S6K and Akt Inhibitor, for Treatment of PAM Pathway-Altered Cancers
Lizbeth DeSelm, Bayard Huck, Ruoxi Lan, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 5, 2021
Discovery of 4-aminopyrimidine analogs as highly potent dual P70S6K/Akt inhibitors
Yufang Xiao, Bayard R Huck, Ruoxi Lan, et al.
Micropublication Biology
|
June 12, 2025
Olfactory cues elicit species-specific locomotive responses in poison frog tadpoles
Mina E Phipps, Penelope R Baker, Luise Bachmann, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 2, 2025
Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodies
Ohan Mazigi, David B Langley, Jake Y Henry, et al.
Nature Communications
|
February 8, 2023
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
Romain Rouet, Jake Y Henry, Matt D Johansen, et al.
Micropublication Biology
|
June 19, 2025
Velvety tree ant extract is a chemotaxis repellent for <i>C. elegans</i>
Malaya Gaerlan, Marco Carrillo, Sofia Ceva, et al.
Page
of 16